| Year |
Citation |
Score |
| 2024 |
Chai AWY, Yee SM, Lee HM, Abdul Aziz N, Yee PS, Marzuki M, Wong KW, Chiang AKS, Chow LK, Dai W, Liu TF, Tan LP, Khoo ASB, Lo KW, Lim PV, et al. Establishment and characterization of an Epstein-Barr virus-positive cell line from a non-keratinizing differentiated primary nasopharyngeal carcinoma. Cancer Research Communications. PMID 38358347 DOI: 10.1158/2767-9764.CRC-23-0341 |
0.305 |
|
| 2022 |
Chen L, Chiang YC, Chan LS, Chau WY, Lung ML, Kahn M, Lo KW, Mak NK, Lung HL. The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma. Cancers. 14. PMID 35804897 DOI: 10.3390/cancers14133125 |
0.301 |
|
| 2021 |
Tan KE, Ng WL, Marinov GK, Yu KH, Tan LP, Liau ES, Goh SY, Yeo KS, Yip KY, Lo KW, Khoo AS, Yap LF, Ea CK, Lim YY. Identification and characterization of a novel Epstein-Barr Virus-encoded circular RNA from LMP-2 Gene. Scientific Reports. 11: 14392. PMID 34257379 DOI: 10.1038/s41598-021-93781-w |
0.307 |
|
| 2021 |
Bruce JP, To KF, Lui VWY, Chung GTY, Chan YY, Tsang CM, Yip KY, Ma BBY, Woo JKS, Hui EP, Mak MKF, Lee SD, Chow C, Velapasamy S, Or YYY, ... ... Lo KW, et al. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape. Nature Communications. 12: 4193. PMID 34234122 DOI: 10.1038/s41467-021-24348-6 |
0.301 |
|
| 2021 |
Chan LKY, Lau TS, Chung KY, Tam C, Cheung TH, Yim SF, Lee JHS, Leung RWT, Qin J, Or YYY, Lo KW, Kwong J. Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth. Cancers. 13. PMID 33652749 DOI: 10.3390/cancers13050980 |
0.31 |
|
| 2020 |
Xue Z, Lui VWY, Li Y, Jia L, You C, Li X, Piao W, Yuan H, Khong PL, Lo KW, Cheung LWT, Lee VHF, Lee AWM, Tsao SW, Tsang CM. Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 39: 262. PMID 33243298 DOI: 10.1186/s13046-020-01763-z |
0.306 |
|
| 2020 |
Zhu J, Li L, Tong J, Hui C, Wong CH, Lo KW, Chan R, Ai QY, Hui EP, Chan AT, To KF, Tao Q, Ma BB. Targeting the polycomb repressive complex-2 related proteins with novel combinational strategies for nasopharyngeal carcinoma. American Journal of Cancer Research. 10: 3267-3284. PMID 33163269 |
0.359 |
|
| 2020 |
Chan LS, Lung HL, Ngan RK, Lee AW, Tsao SW, Lo KW, Kahn M, Lung ML, Wieser R, Mak NK. Role of miR-96/EVI1/miR-449a Axis in the Nasopharyngeal Carcinoma Cell Migration and Tumor Sphere Formation. International Journal of Molecular Sciences. 21. PMID 32752071 DOI: 10.3390/Ijms21155495 |
0.375 |
|
| 2020 |
Chau SL, Tong JH, Chow C, Kwan JS, Lung RW, Chung LY, Tin EK, Wong SS, Cheung AH, Lau RW, Ng CS, Mok TS, Lo KW, To KF. Distinct Molecular Landscape of Epstein-Barr Virus Associated Pulmonary Lymphoepithelioma-Like Carcinoma Revealed by Genomic Sequencing. Cancers. 12. PMID 32726920 DOI: 10.3390/Cancers12082065 |
0.397 |
|
| 2020 |
Hau PM, Lung HL, Wu M, Tsang CM, Wong KL, Mak NK, Lo KW. Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma. Frontiers in Oncology. 10: 600. PMID 32528868 DOI: 10.3389/Fonc.2020.00600 |
0.356 |
|
| 2020 |
Ngan HL, Poon PHY, Su YX, Chan JYK, Lo KW, Yeung CK, Liu Y, Wong E, Li H, Lau CW, Piao W, Lui VWY. Erlotinib sensitivity of p.D321N mutation in head and neck squamous cell carcinoma. Npj Genomic Medicine. 5: 17. PMID 32351709 DOI: 10.1038/S41525-020-0124-5 |
0.348 |
|
| 2020 |
Ngan HL, Poon PHY, Su Y, Chan JYK, Lo K, Yeung CK, Liu Y, Wong E, Li H, Lau CW, Piao W, Lui VWY. Abstract 1792: MAPK1 p.D321N mutation confers sensitive to erlotinib in head and neck squamous cell carcinoma (HNSCC) Cancer Research. 80: 1792-1792. DOI: 10.1158/1538-7445.Am2020-1792 |
0.38 |
|
| 2019 |
Jiang L, Lung HL, Huang T, Lan R, Zha S, Chan LS, Thor W, Tsoi TH, Chau HF, Boreström C, Cobb SL, Tsao SW, Bian ZX, Law GL, Wong WT, ... ... Lo KW, et al. Reactivation of Epstein-Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn-chelating function. Proceedings of the National Academy of Sciences of the United States of America. PMID 31822610 DOI: 10.1073/Pnas.1915372116 |
0.395 |
|
| 2019 |
Yiu SPT, Hui KF, Münz C, Lo KW, Tsao SW, Kao RYT, Yang D, Chiang AKS. Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma. Cancers. 11. PMID 31769432 DOI: 10.3390/Cancers11121871 |
0.373 |
|
| 2019 |
Tsang CM, Yan Lui VW, Bruce JP, Pugh TJ, Lo KW. Translational Genomics of Nasopharyngeal Cancer. Seminars in Cancer Biology. PMID 31521748 DOI: 10.1016/j.semcancer.2019.09.006 |
0.314 |
|
| 2018 |
Siu EH, Chan AW, Chong CC, Chan SL, Lo KW, Cheung ST. Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment. Translational Gastroenterology and Hepatology. 3: 89. PMID 30603725 DOI: 10.21037/Tgh.2018.10.16 |
0.352 |
|
| 2018 |
Chan LS, Man OY, Kwok HH, Chen L, Chan KC, Lung HL, Ngan RK, Wong RN, Lo KW, Lee AW, Tsao GS, Kahn M, Lung ML, Mak NK. The Wnt modulator ICG‑001 mediates the inhibition of nasopharyngeal carcinoma cell migration in vitro via the miR‑150/CD44 axis. International Journal of Oncology. PMID 30569106 DOI: 10.3892/Ijo.2018.4664 |
0.394 |
|
| 2018 |
Lin W, Yip YL, Jia L, Deng W, Zheng H, Dai W, Ko JMY, Lo KW, Chung GTY, Yip KY, Lee SD, Kwan JS, Zhang J, Liu T, Chan JY, et al. Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma. Nature Communications. 9: 4663. PMID 30405107 DOI: 10.1038/S41467-018-06889-5 |
0.324 |
|
| 2018 |
Zhang J, Zhou Y, Huang T, Wu F, Pan Y, Dong Y, Wang Y, Chan AKY, Liu L, Kwan JSH, Cheung AHK, Wong CC, Lo AKF, Cheng ASL, Yu J, ... Lo KW, et al. FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p. Oncogene. PMID 30082912 DOI: 10.1038/S41388-018-0430-X |
0.31 |
|
| 2018 |
Lo AK, Lung RW, Dawson CW, Young LS, Ko CW, Yeung WW, Kang W, To KF, Lo KW. Activation of SREBP1-mediated lipogenesis by the Epstein-Barr Virus-encoded LMP1 promotes cell proliferation and progression of nasopharyngeal carcinoma. The Journal of Pathology. PMID 29968360 DOI: 10.1002/Path.5130 |
0.474 |
|
| 2018 |
Ngan HL, Wang L, Lo KW, Lui VWY. Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer. Cancers. 10. PMID 29933636 DOI: 10.3390/Cancers10070210 |
0.383 |
|
| 2018 |
Wong CH, Ma BBY, Hui CWC, Lo KW, Hui EP, Chan ATC. Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma. Scientific Reports. 8: 8010. PMID 29789630 DOI: 10.1038/S41598-018-26201-1 |
0.376 |
|
| 2018 |
Yip YL, Lin W, Deng W, Jia L, Lo KW, Busson P, Vérillaud B, Liu X, Tsang CM, Lung ML, Tsao SW. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 29769697 DOI: 10.1038/S41374-018-0034-7 |
0.312 |
|
| 2018 |
Lung RW, Hau P, Tong JH, Lam K, Chan AW, Yip KY, Tsao GS, Lo K, To K. Abstract 482: Epstein-Barr virus-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma Cancer Research. 78: 482-482. DOI: 10.1158/1538-7445.Am2018-482 |
0.398 |
|
| 2018 |
Lam K, Lung RW, Hau P, Yip KY, Tsao GS, Yu KH, Tong JH, Lo K, To K. Abstract 2462: Epstein-Barr virus-encoded microRNAs regulate the expression of BRCA1 in nasopharyngeal carcinoma Cancer Research. 78: 2462-2462. DOI: 10.1158/1538-7445.Am2018-2462 |
0.439 |
|
| 2017 |
Lung RW, Hau PM, Yu KH, Yip KY, Tong JH, Chak WP, Chan AW, Lam KH, Lo AK, Tin EK, Chau SL, Pang JC, Kwan JS, Busson P, Young LS, ... ... Lo KW, et al. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. The Journal of Pathology. PMID 29230817 DOI: 10.1002/Path.5018 |
0.412 |
|
| 2017 |
Lui VWY, To KF, Lo KW. Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays. Cancer. PMID 29165785 DOI: 10.1002/Cncr.31131 |
0.369 |
|
| 2017 |
Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 372. PMID 28893937 DOI: 10.1098/rstb.2016.0270 |
0.307 |
|
| 2017 |
Lo AK, Dawson CW, Young LS, Lo KW. The role of Metabolic Reprogramming in γ-Herpesvirus-associated Oncogenesis. International Journal of Cancer. PMID 28542909 DOI: 10.1002/Ijc.30795 |
0.319 |
|
| 2017 |
Lee HM, Lo KW, Wei W, Tsao SW, Chung GT, Ibrahim MH, Dawson CW, Murray PG, Paterson IC, Yap LF. Oncogenic S1P signalling in EBV-associated nasopharyngeal carcinoma activates AKT and promotes cell migration through S1P receptor 3. The Journal of Pathology. PMID 28240350 DOI: 10.1002/Path.4879 |
0.414 |
|
| 2017 |
Li YY, Chung GT, Lui VW, To KF, Ma BB, Chow C, Woo JK, Yip KY, Seo J, Hui EP, Mak MK, Rusan M, Chau NG, Or YY, Law MH, ... ... Lo KW, et al. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations. Nature Communications. 8: 14121. PMID 28098136 DOI: 10.1038/Ncomms14121 |
0.383 |
|
| 2016 |
Chak WP, Lung RW, Tong JH, Chan SY, Lun SW, Tsao SW, Lo KW, To KF. Down-regulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma. Molecular Carcinogenesis. PMID 27597634 DOI: 10.1002/Mc.22569 |
0.42 |
|
| 2016 |
Cheung CC, Lun SW, Chung GT, Chow C, Lo C, Choy KW, Lo KW. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma. Bmc Cancer. 16: 495. PMID 27431799 DOI: 10.1186/S12885-016-2525-5 |
0.424 |
|
| 2016 |
Xu M, Cheung CC, Chow C, Lun SW, Cheung ST, Lo KW. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma. Plos One. 11: e0156833. PMID 27258148 DOI: 10.1371/Journal.Pone.0156833 |
0.431 |
|
| 2016 |
Tsang DP, Wu WK, Kang W, Lee YY, Wu F, Yu Z, Xiong L, Chan AW, Tong JH, Yang W, Li MS, Lau SS, Li X, Lee SD, Yang Y, ... ... Lo KW, et al. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates Nuclear Factor-κB in hepatocellular carcinoma. The Journal of Pathology. PMID 26800240 DOI: 10.1002/Path.4688 |
0.404 |
|
| 2016 |
Lung RW, Hau TP, Chak W, Tong JH, Yu KH, Tsao S, Yip KY, To K, Lo K. Abstract 1118: The role of Epstein-Barr virus-encoded miRNAs in ATM regulating DNA damage response in nasopharyngeal carcinoma Cancer Research. 76: 1118-1118. DOI: 10.1158/1538-7445.Am2016-1118 |
0.41 |
|
| 2015 |
Lo AK, Dawson CW, Young LS, Ko CW, Hau PM, Lo KW. Activation of the FGFR1 signalling pathway by the Epstein-Barr Virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells. The Journal of Pathology. PMID 26096068 DOI: 10.1002/Path.4575 |
0.417 |
|
| 2015 |
Chan KC, Chan LS, Ip JC, Lo C, Yip TT, Ngan RK, Wong RN, Lo KW, Ng WT, Lee AW, Tsao GS, Kahn M, Lung ML, Mak NK. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Scientific Reports. 5: 9979. PMID 25897700 DOI: 10.1038/Srep09979 |
0.332 |
|
| 2015 |
Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. The Journal of Pathology. 235: 323-33. PMID 25251730 DOI: 10.1002/Path.4448 |
0.441 |
|
| 2015 |
Yip TTC, Ngan RKC, Ng W, Chan LTC, Tai WCS, Cheng W, Ma VWS, Lo K, Li Y, Yang MBH, Wong ECH, Ma BBY, Mak N, Tsao GSW, Li-Lung M. Abstract 1734: Preclinical study of HSP-90 inhibitor drug, AUY922 showed good efficacy in treatment of nasopharyngeal cancer Cancer Research. 75: 1734-1734. DOI: 10.1158/1538-7445.Am2015-1734 |
0.424 |
|
| 2014 |
Tso KY, Lee SD, Lo KW, Yip KY. Are special read alignment strategies necessary and cost-effective when handling sequencing reads from patient-derived tumor xenografts? Bmc Genomics. 15: 1172. PMID 25539684 DOI: 10.1186/1471-2164-15-1172 |
0.329 |
|
| 2014 |
Lun SW, Cheung ST, Lo KW. Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma. Chinese Journal of Cancer. 33: 529-38. PMID 25223912 DOI: 10.5732/Cjc.014.10081 |
0.41 |
|
| 2014 |
Yuen JW, Chung GT, Lun SW, Cheung CC, To KF, Lo KW. Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma. Plos One. 9: e105163. PMID 25126743 DOI: 10.1371/Journal.Pone.0105163 |
0.482 |
|
| 2014 |
Cheung CC, Chung GT, Lun SW, To KF, Choy KW, Lau KM, Siu SP, Guan XY, Ngan RK, Yip TT, Busson P, Tsao SW, Lo KW. miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis. Molecular Cancer. 13: 184. PMID 25098679 DOI: 10.1186/1476-4598-13-184 |
0.341 |
|
| 2014 |
Tsao SW, Yip YL, Tsang CM, Pang PS, Lau VM, Zhang G, Lo KW. Etiological factors of nasopharyngeal carcinoma. Oral Oncology. 50: 330-8. PMID 24630258 DOI: 10.1016/j.oraloncology.2014.02.006 |
0.303 |
|
| 2014 |
Gressette M, Vérillaud B, Jimenez-Pailhès AS, Lelièvre H, Lo KW, Ferrand FR, Gattolliat CH, Jacquet-Bescond A, Kraus-Berthier L, Depil S, Busson P. Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts. Plos One. 9: e91325. PMID 24618637 DOI: 10.1371/Journal.Pone.0091325 |
0.364 |
|
| 2014 |
Lau TS, Chung TK, Cheung TH, Chan LK, Cheung LW, Yim SF, Siu NS, Lo KW, Yu MM, Kulbe H, Balkwill FR, Kwong J. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts. The Journal of Pathology. 232: 43-56. PMID 24014111 DOI: 10.1002/Path.4258 |
0.36 |
|
| 2014 |
Mak CK, Chung GT, Yip KY, Tso KK, Lee S, Cheung S, Tsao S, Busson P, To K, Lo K. Abstract 3425: Whole-transcriptome analyses of EBV-associated nasopharyngeal carcinoma using next-generation transcriptome sequencing Cancer Research. 74: 3425-3425. DOI: 10.1158/1538-7445.Am2014-3425 |
0.48 |
|
| 2013 |
Chan KC, Ting CM, Chan PS, Lo MC, Lo KW, Curry JE, Smyth T, Lee AW, Ng WT, Tsao GS, Wong RN, Lung ML, Mak NK. A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation. Molecular Cancer. 12: 128. PMID 24156782 DOI: 10.1186/1476-4598-12-128 |
0.367 |
|
| 2013 |
Tso KK, Yip KY, Mak CK, Chung GT, Lee SD, Cheung ST, To KF, Lo KW. Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1. Infectious Agents and Cancer. 8: 29. PMID 23915735 DOI: 10.1186/1750-9378-8-29 |
0.418 |
|
| 2013 |
Chung GT, Lung RW, Hui AB, Yip KY, Woo JK, Chow C, Tong CY, Lee SD, Yuen JW, Lun SW, Tso KK, Wong N, Tsao SW, Yip TT, Busson P, ... ... Lo KW, et al. Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma. The Journal of Pathology. 231: 158-67. PMID 23878065 DOI: 10.1002/Path.4240 |
0.457 |
|
| 2013 |
Chung GT, Lou WP, Chow C, To KF, Choy KW, Leung AW, Tong CY, Yuen JW, Ko CW, Yip TT, Busson P, Lo KW. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. The Journal of Pathology. 231: 311-22. PMID 23868181 DOI: 10.1002/Path.4239 |
0.42 |
|
| 2013 |
Lo AK, Lo KW, Ko CW, Young LS, Dawson CW. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells. The Journal of Pathology. 230: 336-46. PMID 23592276 DOI: 10.1002/Path.4201 |
0.425 |
|
| 2013 |
Lo MC, Yip TC, Ngan KC, Cheng WW, Law CK, Chan PS, Chan KC, Wong CK, Wong RN, Lo KW, Ng WT, Lee WM, Tsao SW, Kwong LW, Lung ML, et al. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres. Cancer Letters. 335: 81-92. PMID 23403077 DOI: 10.1016/J.Canlet.2013.01.052 |
0.395 |
|
| 2013 |
Vérillaud B, Gressette M, Jimenez A, Lelièvre H, Lo K, Jacquet-Bescond A, Kraus-Berthier L, Depil S, Busson P. Abstract 1013: Treatment of EBV-positive nasopharyngeal carcinoma xenografts with the HDAC-inhibitor Abexinostat: synergy with cis-platinum. Cancer Research. 73: 1013-1013. DOI: 10.1158/1538-7445.Am2013-1013 |
0.416 |
|
| 2012 |
Lun SW, Cheung ST, Cheung PF, To KF, Woo JK, Choy KW, Chow C, Cheung CC, Chung GT, Cheng AS, Ko CW, Tsao SW, Busson P, Ng MH, Lo KW. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. Plos One. 7: e52426. PMID 23285037 DOI: 10.1371/Journal.Pone.0052426 |
0.448 |
|
| 2012 |
Lo AK, Dawson CW, Jin DY, Lo KW. The pathological roles of BART miRNAs in nasopharyngeal carcinoma. The Journal of Pathology. 227: 392-403. PMID 22431062 DOI: 10.1002/Path.4025 |
0.347 |
|
| 2012 |
Lo KW, Chung GT, To KF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Seminars in Cancer Biology. 22: 79-86. PMID 22245473 DOI: 10.1016/J.Semcancer.2011.12.011 |
0.351 |
|
| 2012 |
Man CH, Wei-Man Lun S, Wai-Ying Hui J, To KF, Choy KW, Wing-Hung Chan A, Chow C, Tin-Yun Chung G, Tsao SW, Tak-Chun Yip T, Busson P, Lo KW. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma. The Journal of Pathology. 226: 471-81. PMID 22009689 DOI: 10.1002/Path.2997 |
0.457 |
|
| 2012 |
Cheung CC, Chung GT, Lun SW, Choy K, To K, Lo K. Abstract 2288: Genetic and epigenetic inactivation of miR-31 in EBV-associated nasopharyngeal carcinoma Cancer Research. 72: 2288-2288. DOI: 10.1158/1538-7445.Am2012-2288 |
0.391 |
|
| 2010 |
Chan SY, To KF, Leung SF, Yip WW, Mak MK, Chung GT, Lo KW. 14-3-3sigma expression as a prognostic marker in undifferentiated nasopharyngeal carcinoma. Oncology Reports. 24: 949-55. PMID 20811675 DOI: 10.3892/or-00000941 |
0.314 |
|
| 2010 |
Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, O'Sullivan B, Liu FF. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. International Journal of Cancer. Journal International Du Cancer. 126: 2036-48. PMID 19739117 DOI: 10.1002/Ijc.24880 |
0.392 |
|
| 2010 |
Or YY, Chung GT, To KF, Chow C, Choy KW, Tong CY, Leung AW, Hui AB, Tsao SW, Ng HK, Yip TT, Busson P, Lo KW. Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. The Journal of Pathology. 220: 97-107. PMID 19718711 DOI: 10.1002/Path.2609 |
0.31 |
|
| 2010 |
Lun SW, Man C, Hui JW, Chow C, Choy K, Kwong J, Lin H, To K, Lo K. Abstract 356: Targeting NOTCH3 signaling pathway enhances chemosensitivity in EBV-positive NPC cells Cancer Research. 70: 356-356. DOI: 10.1158/1538-7445.Am10-356 |
0.479 |
|
| 2009 |
Lung RW, Tong JH, Sung YM, Leung PS, Ng DC, Chau SL, Chan AW, Ng EK, Lo KW, To KF. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia (New York, N.Y.). 11: 1174-84. PMID 19881953 DOI: 10.1593/Neo.09888 |
0.361 |
|
| 2009 |
Kwok WK, Pang JC, Lo KW, Ng HK. Role of the RARRES1 gene in nasopharyngeal carcinoma. Cancer Genetics and Cytogenetics. 194: 58-64. PMID 19737656 DOI: 10.1016/J.Cancergencyto.2009.06.005 |
0.389 |
|
| 2009 |
Chan MW, Hui AB, Yip SK, Ng CF, Lo KW, Tong JH, Chan AW, Cheung HY, Wong WS, Chan PS, Lai FM, To KF. Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization. International Journal of Oncology. 34: 963-70. PMID 19287953 DOI: 10.3892/Ijo_00000222 |
0.317 |
|
| 2008 |
Alajez NM, Mocanu JD, Shi W, Chia MC, Breitbach CJ, Hui AB, Knowles S, Bell JC, Busson P, Takada K, Lo KW, O'Sullivan B, Gullane P, Liu FF. Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4891-7. PMID 18676763 DOI: 10.1158/1078-0432.Ccr-07-4134 |
0.358 |
|
| 2008 |
Wang L, Shan L, Lo KW, Yin J, Zhang Y, Sun R, Zhong J. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP. The Journal of Gene Medicine. 10: 1124-33. PMID 18642396 DOI: 10.1002/Jgm.1237 |
0.351 |
|
| 2008 |
Chang SS, Lo YC, Chua HH, Chiu HY, Tsai SC, Chen JY, Lo KW, Tsai CH. Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression. Journal of Virology. 82: 7745-51. PMID 18495777 DOI: 10.1128/Jvi.02717-07 |
0.418 |
|
| 2007 |
Mocanu JD, Yip KW, Alajez NM, Shi W, Li JH, Lunt SJ, Moriyama EH, Wilson BC, Milosevic M, Lo KW, van Rooijen NV, Busson P, Bastianutto C, Liu FF. Imaging the Modulation of Adenoviral Kinetics and Biodistribution for Cancer Gene Therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 921-929. PMID 28182894 DOI: 10.1038/Mt.Sj.6300119 |
0.371 |
|
| 2007 |
Mocanu JD, Yip KW, Skliarenko J, Shi W, Busson P, Lo KW, Bastianutto C, Liu FF. Imaging and modulating antisense microdistribution in solid human xenograft tumor models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5935-41. PMID 17908990 DOI: 10.1158/1078-0432.Ccr-06-3085 |
0.334 |
|
| 2007 |
Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF, Chan FL, Daigo Y, Nakamura Y, Huang DP, Lo KW. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes, Chromosomes & Cancer. 46: 171-80. PMID 17099870 DOI: 10.1002/Gcc.20398 |
0.49 |
|
| 2007 |
Man C, Rosa J, Lee LT, Lee VH, Chow BK, Lo KW, Doxsey S, Wu ZG, Kwong YL, Jin DY, Cheung AL, Tsao SW. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Oncogene. 26: 3069-80. PMID 17099724 DOI: 10.1038/Sj.Onc.1210106 |
0.458 |
|
| 2006 |
Shi W, Bastianutto C, Li A, Perez-Ordonez B, Ng R, Chow KY, Zhang W, Jurisica I, Lo KW, Bayley A, Kim J, O'Sullivan B, Siu L, Chen E, Liu FF. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. International Journal of Cancer. 119: 2467-75. PMID 16858677 DOI: 10.1002/Ijc.22107 |
0.39 |
|
| 2006 |
Kwong J, Lee JY, Wong KK, Zhou X, Wong DT, Lo KW, Welch WR, Berkowitz RS, Mok SC. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia (New York, N.Y.). 8: 268-78. PMID 16756719 DOI: 10.1593/Neo.05502 |
0.311 |
|
| 2006 |
Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF, Hayward DS, Chui YL, Lau YL, Takada K, Huang DP. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia (New York, N.Y.). 8: 173-80. PMID 16611410 DOI: 10.1593/Neo.05625 |
0.306 |
|
| 2005 |
Wong HL, Wang X, Chang RCC, Jin DY, Feng H, Wang Q, Lo KW, Huang DP, Yuen PW, Takada K, Wong YC, Tsao SW. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress Molecular Carcinogenesis. 44: 92-101. PMID 16086371 DOI: 10.1002/Mc.20133 |
0.384 |
|
| 2005 |
Kwong J, Lo KW, Chow LS, To KF, Choy KW, Chan FL, Mok SC, Huang DP. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma. Neoplasia (New York, N.Y.). 7: 67-74. PMID 15720818 DOI: 10.1593/Neo.04370 |
0.346 |
|
| 2005 |
Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. International Journal of Cancer. 113: 386-92. PMID 15455391 DOI: 10.1002/Ijc.20593 |
0.457 |
|
| 2004 |
Bai AH, Tong JH, To KF, Chan MW, Man EP, Lo KW, Lee JF, Sung JJ, Leung WK. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. International Journal of Cancer. 112: 846-53. PMID 15386372 DOI: 10.1002/Ijc.20485 |
0.366 |
|
| 2004 |
Lo AK, Huang DP, Lo KW, Chui YL, Li HM, Pang JC, Tsao SW. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. International Journal of Cancer. 109: 919-25. PMID 15027126 DOI: 10.1002/Ijc.20051 |
0.339 |
|
| 2004 |
Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. International Journal of Cancer. 109: 839-47. PMID 15027117 DOI: 10.1002/Ijc.20079 |
0.464 |
|
| 2004 |
Chow LS, Lo K, Kwong J, Wong AY, Huang DP. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma Oncology Reports. 12: 781-787. DOI: 10.3892/Or.12.4.781 |
0.365 |
|
| 2003 |
Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Molecular Carcinogenesis. 38: 170-8. PMID 14639656 DOI: 10.1002/Mc.10156 |
0.445 |
|
| 2002 |
Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma Seminars in Cancer Biology. 12: 451-462. PMID 12450731 DOI: 10.1016/S1044579X02000883 |
0.404 |
|
| 2002 |
Kung FY, Tse GM, Lo KW, Law BK, Chang AR, Chen MH. Metachronous bilateral mammary metaplastic and infiltrating duct carcinomas: a molecular study for clonality. Human Pathology. 33: 677-9. PMID 12152169 DOI: 10.1053/Hupa.2002.124906 |
0.375 |
|
| 2002 |
Lo KW, Tsang YS, Kwong J, To KF, Teo PM, Huang DP. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. International Journal of Cancer. 98: 651-5. PMID 11920632 DOI: 10.1002/Ijc.10271 |
0.427 |
|
| 2002 |
Hui AB, Lo KW, Chan SY, Kwong J, Chan AS, Huang DP. Absence of SDHD mutations in primary nasopharyngeal carcinomas. International Journal of Cancer. 97: 875-7. PMID 11857371 DOI: 10.1002/Ijc.10066 |
0.309 |
|
| 2002 |
Hui AB, Lo K, Teo PML, To K, Huang DP. Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. International Journal of Oncology. 20: 467-473. DOI: 10.3892/Ijo.20.3.467 |
0.377 |
|
| 1999 |
Liew CT, Li HM, Lo KW, Leow CK, Chan JY, Hin LY, Lau WY, Lai PB, Lim BK, Huang J, Leung WT, Wu S, Lee JC. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene. 18: 789-95. PMID 9989830 DOI: 10.1038/Sj.Onc.1202359 |
0.386 |
|
| 1999 |
Ng MH, Kan A, Chung YF, Wong IH, Lo KW, Wickham NW, Lei KI, Lee JC. Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients. The American Journal of Pathology. 154: 15-22. PMID 9916913 DOI: 10.1016/S0002-9440(10)65245-5 |
0.31 |
|
| 1998 |
Hui ABY, Cheung ST, Fong Y, Lo KW, Huang DP. Characterization of a new EBV-associated nasopharyngeal carcinoma cell line Cancer Genetics and Cytogenetics. 101: 83-88. PMID 9494607 DOI: 10.1016/S0165-4608(97)00231-8 |
0.402 |
|
| 1997 |
Tse JY, Wong JH, Lo KW, Poon WS, Huang DP, Ng HK. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas. American Journal of Clinical Pathology. 107: 459-66. PMID 9124215 DOI: 10.1093/Ajcp/107.4.459 |
0.334 |
|
| 1996 |
Cheung ST, Lo KW, Leung SF, Chan WY, Choi PH, Johnson PJ, Lee JC, Huang DP. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong International Journal of Cancer. Journal International Du Cancer. 66: 711-712. PMID 8647637 DOI: 10.1002/(Sici)1097-0215(19960529)66:5<711::Aid-Ijc21>3.0.Co;2-5 |
0.369 |
|
| 1993 |
Choi PHK, Suen MWM, Huang DP, Lo K, Lee JCK. Nasopharyngeal carcinoma : genetic changes, Epstein-Barr virus infection, or both : a clinical and molecular study of 36 patients Cancer. 72: 2873-2878. PMID 8106138 DOI: 10.1002/1097-0142(19931115)72:10<2873::Aid-Cncr2820721003>3.0.Co;2-A |
0.382 |
|
| 1991 |
Huang DP, Lo KW, Choi PH, Ng AY, Tsao SY, Yiu GK, Lee JC. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genetics and Cytogenetics. 54: 91-9. PMID 1676610 DOI: 10.1016/0165-4608(91)90035-S |
0.371 |
|
| Show low-probability matches. |